Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata ...Middle East

PR Newswire - News
LONDON, Nov. 1, 2023 /PRNewswire/ -- Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild / moderate (patchy) alopecia areata. Final results of the study are anticipated...

Hence then, the article about soterios pharma completes phase ii enrolment for sts 01 in mild moderate patchy alopecia areata was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News